Immucell (IUL) Financial Statements
Immucell Financial Overview
Immucell's market cap is currently $83.44M. The company's EPS TTM is $0.08; its P/E ratio is 121.28; Immucell has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 27.64M | $ 26.49M | $ 17.47M | $ 18.57M | $ 19.24M |
| Gross Profit | $ 11.45M | $ 7.94M | $ 4.40M | $ 7.65M | $ 8.66M |
| Operating Income | $ 1.65M | $ -1.64M | $ -5.75M | $ -2.30M | $ 257.38K |
| EBITDA | $ 2.14M | $ 1.07M | $ -2.50M | $ 349.99K | $ 2.70M |
| Net Income | $ -1.04M | $ -2.16M | $ -5.77M | $ -2.49M | $ -78.29K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.81M | $ 3.76M | $ 978.74K | $ 5.79M | $ 10.19M |
| Total Assets | $ 42.53M | $ 45.10M | $ 43.81M | $ 44.86M | $ 44.47M |
| Total Debt | $ 13.19M | $ 15.10M | $ 16.69M | $ 12.48M | $ 10.27M |
| Net Debt | $ 9.39M | $ 11.34M | $ 15.71M | $ 6.69M | $ 89.03K |
| Total Liabilities | $ 15.48M | $ 17.58M | $ 18.82M | $ 14.48M | $ 11.89M |
| Stockholders' Equity | $ 27.06M | $ 27.52M | $ 24.99M | $ 30.38M | $ 32.58M |
| Cash Flow | |||||
| Free Cash Flow | $ 1.22M | $ -107.82K | $ -6.57M | $ -5.52M | $ -1.65M |
| Operating Cash Flow | $ 2.48M | $ 357.90K | $ -4.67M | $ -1.54M | $ 954.17K |
| Investing Cash Flow | $ -1.21M | $ -461.23K | $ -1.89M | $ -3.96M | $ -1.60M |
| Financing Cash Flow | $ -1.21M | $ 2.88M | $ 1.75M | $ 1.11M | $ 3.88M |
Currency in USD
